With global perspective while rooted in China, InnoCare is a biopharmaceutical company focused on discovery and development of innovative drug for treatment of cancer and autoimmune diseases. Founded by world-renowned structural biologists and world top scientists, InnoCare has a core scientific team with solid education background and rich drug discovery experience in the US and a strong Scientific Advisory Board (SAB) which consists of academic leaders from top universities, famous scientists from pharmaceutical industry and clinical experts from national top hospitals. InnoCare is aggressively forging an important pathway forward in defeating disease and pushing the innovation boundaries into unchartered territories.

InnoCare是一家植根中國且具全球視野的新藥創(chuàng)制公司。公司由世界著名的結(jié)構(gòu)生物學(xué)家和在國際頂尖制藥公司積累數(shù)十年經(jīng)驗(yàn)的新藥研究專家共同發(fā)起設(shè)立，核心研究團(tuán)隊(duì)成員都有長期在美國學(xué)習(xí)和在跨國制藥公司擔(dān)任研發(fā)高管的經(jīng)歷。他們與由來自清華、北大的生命科學(xué)領(lǐng)域?qū)W術(shù)帶頭人、跨國制藥公司新藥研究專家以及國內(nèi)頂尖醫(yī)院的醫(yī)療專家組成的科學(xué)顧問委員會(huì)一起，構(gòu)成公司核心競爭力的重要組成部分。